Grant Angus has filed 4 insider transactions across 1 company since March 2024.
Most recent transaction: a option exercise of 12913 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) on August 09, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 9, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Grant Angus | EVP, Business Development | M | Ordinary Shares | 12913 | $0.00 | 12,913.0000 | 1,133,000,000 | 9999.99% | 0.00% |
| Aug. 9, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Grant Angus | EVP, Business Development | S | Ordinary Shares | 4065 | $17.28 | 8,848.0000 | 1,133,000,000 | 31.48% | 0.00% |
| Aug. 9, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Grant Angus | EVP, Business Development | M | Restricted Share Units | 12913 | $0.00 | 38,739.0000 | 1,133,000,000 | 25.00% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Grant Angus | EVP, Business Development | A | Restricted Share Units | 52083 | $0.00 | 52,083.0000 | 1,119,000,000 | 9999.99% | 0.00% |